Loading chat...

VA HB1347

Bill

Status

Enrolled

3/2/2026

Primary Sponsor

Laura Jane Cohen

Click for details

Origin

House of Delegates

2026 Regular Regular Session

AI Summary

  • Directs the Virginia Board of Pharmacy to reschedule FDA-approved psilocybin formulations designed for administration by health care professionals in health care settings
  • Rescheduling must occur at the Board's next quarterly meeting following 30 days after federal scheduling changes are published in the Federal Register
  • Applies only to specific psilocybin formulations approved by the U.S. Food and Drug Administration, not to psilocybin generally
  • Aligns Virginia's controlled substance scheduling with federal changes through existing procedures in § 54.1-3443 of the Code of Virginia

Legislative Description

Psilocybin; Board of Pharmacy to reschedule upon federal scheduling changes.

Last Action

Governor's Action Deadline 11:59 p.m., April 13, 2026

3/10/2026

Committee Referrals

Education and Health2/12/2026
Health and Human Services: Health1/23/2026
Health and Human Services1/19/2026

Full Bill Text

No bill text available